ASND logo

Ascendis Pharma A/S (ASND) Operating Profit

Annual Operating Profit

-$301.72 M
+$191.45 M+38.82%

December 31, 2024


Summary


Performance

ASND Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherASNDprofitabilitymetrics:

Quarterly Operating Profit

$408.30 K
+$106.81 M+100.38%

December 31, 2024


Summary


Performance

ASND Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherASNDprofitabilitymetrics:

TTM Operating Profit

-$302.86 M
+$39.84 M+11.62%

December 31, 2024


Summary


Performance

ASND TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherASNDprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

ASND Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.8%+100.3%+20.9%
3 y3 years+43.6%+100.3%+20.9%
5 y5 years-18.9%+100.3%+20.9%

ASND Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+49.1%at high+100.3%at high+49.9%
5 y5-year-18.9%+49.1%at high+100.3%-19.4%+49.9%
alltimeall time-4403.5%+49.1%-86.8%+100.3%-9853.5%+49.9%

Ascendis Pharma A/S Operating Profit History

DateAnnualQuarterlyTTM
Dec 2024
-$301.72 M(-38.8%)
$408.30 K(-100.4%)
-$302.86 M(-11.6%)
Sep 2024
-
-$106.40 M(-25.8%)
-$342.69 M(-10.4%)
Jun 2024
-
-$143.48 M(+168.8%)
-$382.63 M(-2.6%)
Mar 2024
-
-$53.38 M(+35.4%)
-$392.72 M(-20.4%)
Dec 2023
-$493.17 M(-16.8%)
-$39.43 M(-73.1%)
-$493.67 M(-18.4%)
Sep 2023
-
-$146.34 M(-4.7%)
-$604.94 M(+0.1%)
Jun 2023
-
-$153.57 M(-0.5%)
-$604.17 M(+0.4%)
Mar 2023
-
-$154.32 M(+2.4%)
-$601.74 M(+1.8%)
Dec 2022
-$592.49 M(+10.8%)
-$150.71 M(+3.5%)
-$591.08 M(+3.9%)
Sep 2022
-
-$145.57 M(-3.7%)
-$569.13 M(+5.8%)
Jun 2022
-
-$151.14 M(+5.2%)
-$537.85 M(+1.8%)
Mar 2022
-
-$143.66 M(+11.6%)
-$528.48 M(-1.2%)
Dec 2021
-$534.55 M(+41.6%)
-$128.76 M(+12.7%)
-$535.02 M(+2.8%)
Sep 2021
-
-$114.29 M(-19.4%)
-$520.29 M(+4.4%)
Jun 2021
-
-$141.76 M(-5.6%)
-$498.18 M(+11.3%)
Mar 2021
-
-$150.21 M(+31.7%)
-$447.77 M(+18.3%)
Dec 2020
-$377.58 M(+48.8%)
-$114.04 M(+23.7%)
-$378.35 M(+12.6%)
Sep 2020
-
-$92.18 M(+0.9%)
-$336.12 M(+10.6%)
Jun 2020
-
-$91.35 M(+13.1%)
-$304.00 M(+12.3%)
Mar 2020
-
-$80.78 M(+12.5%)
-$270.59 M(+6.6%)
Dec 2019
-$253.81 M
-$71.81 M(+19.6%)
-$253.74 M(+13.9%)
Sep 2019
-
-$60.06 M(+3.7%)
-$222.84 M(+7.5%)
Jun 2019
-
-$57.94 M(-9.4%)
-$207.30 M(+1.8%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$63.93 M(+56.3%)
-$203.62 M(+11.3%)
Dec 2018
-$182.74 M(+44.7%)
-$40.91 M(-8.1%)
-$182.90 M(+1.9%)
Sep 2018
-
-$44.52 M(-18.0%)
-$179.48 M(+4.4%)
Jun 2018
-
-$54.26 M(+25.6%)
-$171.97 M(+18.7%)
Mar 2018
-
-$43.21 M(+15.2%)
-$144.85 M(+14.3%)
Dec 2017
-$126.32 M(+56.5%)
-$37.49 M(+1.3%)
-$126.73 M(+11.9%)
Sep 2017
-
-$37.00 M(+36.3%)
-$113.23 M(+17.6%)
Jun 2017
-
-$27.14 M(+8.1%)
-$96.30 M(+12.1%)
Mar 2017
-
-$25.10 M(+4.6%)
-$85.89 M(+6.7%)
Dec 2016
-$80.71 M(+73.9%)
-$23.99 M(+19.5%)
-$80.53 M(+12.0%)
Sep 2016
-
-$20.07 M(+19.9%)
-$71.87 M(+19.9%)
Jun 2016
-
-$16.73 M(-15.2%)
-$59.93 M(+4.4%)
Mar 2016
-
-$19.74 M(+28.8%)
-$57.39 M(+24.0%)
Dec 2015
-$46.41 M(+191.1%)
-$15.33 M(+88.5%)
-$46.29 M(+16.4%)
Sep 2015
-
-$8.13 M(-42.7%)
-$39.78 M(+14.9%)
Jun 2015
-
-$14.19 M(+64.2%)
-$34.62 M(+47.8%)
Mar 2015
-
-$8.64 M(-2.0%)
-$23.41 M(+51.3%)
Dec 2014
-$15.94 M(-327.4%)
-$8.82 M(+197.3%)
-$15.47 M(+335.9%)
Sep 2014
-
-$2.97 M(-0.8%)
-$3.55 M(+508.2%)
Jun 2014
-
-$2.99 M(+327.9%)
-$583.60 K(-124.3%)
Mar 2014
-
-$698.70 K(-122.5%)
$2.41 M(-22.5%)
Dec 2013
$7.01 M(+260.4%)
$3.11 M
$3.11 M
Dec 2012
$1.95 M
-
-

FAQ

  • What is Ascendis Pharma A/S annual operating income?
  • What is the all time high annual operating profit for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual operating profit year-on-year change?
  • What is Ascendis Pharma A/S quarterly operating income?
  • What is the all time high quarterly operating profit for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly operating profit year-on-year change?
  • What is Ascendis Pharma A/S TTM operating income?
  • What is the all time high TTM operating profit for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S TTM operating profit year-on-year change?

What is Ascendis Pharma A/S annual operating income?

The current annual operating profit of ASND is -$301.72 M

What is the all time high annual operating profit for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual operating income is $7.01 M

What is Ascendis Pharma A/S annual operating profit year-on-year change?

Over the past year, ASND annual operating income has changed by +$191.45 M (+38.82%)

What is Ascendis Pharma A/S quarterly operating income?

The current quarterly operating profit of ASND is $408.30 K

What is the all time high quarterly operating profit for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly operating income is $3.11 M

What is Ascendis Pharma A/S quarterly operating profit year-on-year change?

Over the past year, ASND quarterly operating income has changed by +$143.89 M (+100.28%)

What is Ascendis Pharma A/S TTM operating income?

The current TTM operating profit of ASND is -$302.86 M

What is the all time high TTM operating profit for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high TTM operating income is $3.11 M

What is Ascendis Pharma A/S TTM operating profit year-on-year change?

Over the past year, ASND TTM operating income has changed by +$79.78 M (+20.85%)